1. Anti-infection Cell Cycle/DNA Damage Immunology/Inflammation Apoptosis
  2. Bacterial Antibiotic DNA/RNA Synthesis Interleukin Related Apoptosis
  3. Clofazimine

Clofazimine is an orally-active anti-mycobacterial agent with a wide range of anti-mycobacterial activity including leprosy and tuberculosis. Clofazimine exerts anti-inflammatory activities and anti-tumor activities by interfering DNA replication and inhibiting IL2 (IC50 = 1.10 ± 0.26 μM, Jurkat T) production. Clofazimine can be used in mycobacterial and cancer research.

For research use only. We do not sell to patients.

CAS No. : 2030-63-9

Size Price Stock Quantity
Solid + Solvent (Highly Recommended)
10 mM * 1 mL in DMSO
ready for reconstitution
In-stock
Solution
10 mM * 1 mL in DMSO In-stock
Solid
500 mg In-stock
1 g In-stock
5 g In-stock
10 g In-stock
50 g   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Customer Review

Based on 12 publication(s) in Google Scholar

Other Forms of Clofazimine:

Top Publications Citing Use of Products

    Clofazimine purchased from MedChemExpress. Usage Cited in: Sci Adv. 2025 Mar 21;11(12):eads9182.  [Abstract]

    Clofazimine (15 μM; 24 h) significantly blocked OA-induced expression of H3K4me3-controlled genes AGR2 and PARM1, with a trend toward reduced PHGDH and NTRK2 expression in microstructures from BRCA1 wild-type individuals.

    Clofazimine purchased from MedChemExpress. Usage Cited in: Commun Biol. 2025 Oct 6;8(1):1425.  [Abstract]

    Clofazimine (CFZ) (3.125 μg/mL; 48 h) markedly reduced the survival of ΔcysE Mycobacterium tuberculosis H37Rv.

    Clofazimine purchased from MedChemExpress. Usage Cited in: Commun Biol. 2025 Oct 6;8(1):1425.  [Abstract]

    Clofazimine (CFZ) (15.625-31.25 μg/mL; 1-3 h) strongly increased ROS levels in M. tb (Mycobacterium tuberculosis).

    Clofazimine purchased from MedChemExpress. Usage Cited in: Commun Biol. 2025 Oct 6;8(1):1425.  [Abstract]

    Early-log-phase cultures of WT and ΔcysE M. tb (Mycobacterium tuberculosis) were treated with or without Clofazimine (CFZ) (3.125–6.25 μg/mL; 7 d). Survival was determined in the form of viable bacterial count expressed as CFU.

    Clofazimine purchased from MedChemExpress. Usage Cited in: Patent. US20250312336A1.

    The weights of orthotopic syngeneic pancreatic tumors from C57BL/6J mice followed treatment with ANO6 inhibitors Clofazimine (50 mg/kg; p.o.; 3 weeks).

    Clofazimine purchased from MedChemExpress. Usage Cited in: Cell Death Discov. 2022 Mar 12;8(1):111.  [Abstract]

    Clofazimine (Verteporfin) (5 μM) reduced the expression of steogenesis related genes (RUNX2, ALP, OSX) in BMSCs.
    • Biological Activity

    • Purity & Documentation

    • References

    • Customer Review

    Description

    Clofazimine is an orally-active anti-mycobacterial agent with a wide range of anti-mycobacterial activity including leprosy and tuberculosis. Clofazimine exerts anti-inflammatory activities and anti-tumor activities by interfering DNA replication and inhibiting IL2 (IC50 = 1.10 ± 0.26 μM, Jurkat T) production. Clofazimine can be used in mycobacterial and cancer research[1][2][3][4][5].

    IC50 & Target

    Quinolone

     

    Cellular Effect
    Cell Line Type Value Description References
    BT-20 IC50
    19 μM
    Compound: Clofazimine
    Cytotoxicity against human BT-20 cells incubated for 3 to 4 days by MTT assay
    Cytotoxicity against human BT-20 cells incubated for 3 to 4 days by MTT assay
    [PMID: 34116325]
    HMEC-1 CC50
    18.6 μM
    Compound: CFM
    Cytotoxicity against human HMEC1 cells assessed as reduction in cell viability after 72 hrs by MTT method
    Cytotoxicity against human HMEC1 cells assessed as reduction in cell viability after 72 hrs by MTT method
    [PMID: 25464882]
    HMEC-1 IC50
    18.59 μM
    Compound: Clofazimine
    Cytotoxicity against HMEC1 cells after 72 hrs by MTT assay
    Cytotoxicity against HMEC1 cells after 72 hrs by MTT assay
    [PMID: 25497962]
    HepG2 CC50
    49.02 μg/mL
    Compound: CLFZ
    Cytotoxicity against human HepG2 cells assessed as reduction in cell viability by MTT assay
    Cytotoxicity against human HepG2 cells assessed as reduction in cell viability by MTT assay
    [PMID: 38784457]
    Huh-7 CC50
    44.7 μM
    Compound: 1
    Cytotoxicity against human HuH-7 cells assessed as reduction in cell viability incubated for 24 hrs by microplate reader assay
    Cytotoxicity against human HuH-7 cells assessed as reduction in cell viability incubated for 24 hrs by microplate reader assay
    [PMID: 35279610]
    MT4 CC50
    6.8 μM
    Compound: CFM
    Cytotoxicity against human MT4 cells assessed as reduction in cell viability after 96 hrs by MTT method
    Cytotoxicity against human MT4 cells assessed as reduction in cell viability after 96 hrs by MTT method
    [PMID: 25464882]
    NIH-3T3-G185 IC50
    0.6 μM
    Compound: Clofazimine
    TP_TRANSPORTER: inhibition of Daunorubicin efflux in NIH-3T3-G185 cells
    TP_TRANSPORTER: inhibition of Daunorubicin efflux in NIH-3T3-G185 cells
    [PMID: 11716514]
    NIH-3T3-G185 IC50
    1 μM
    Compound: Clofazimine
    TP_TRANSPORTER: inhibition of Rhodamine 123 efflux in NIH-3T3-G185 cells
    TP_TRANSPORTER: inhibition of Rhodamine 123 efflux in NIH-3T3-G185 cells
    [PMID: 11716514]
    NIH-3T3-G185 IC50
    1.1 μM
    Compound: Clofazimine
    TP_TRANSPORTER: inhibition of LDS-751 efflux in NIH-3T3-G185 cells
    TP_TRANSPORTER: inhibition of LDS-751 efflux in NIH-3T3-G185 cells
    [PMID: 11716514]
    Vero IC50
    68.6 μg/mL
    Compound: CFZ
    Cytotoxicity against african green monkey Vero cells after 48 hrs by MTT assay
    Cytotoxicity against african green monkey Vero cells after 48 hrs by MTT assay
    [PMID: 22931472]
    Vero 76 CC50
    > 100 μM
    Compound: CFM
    Cytotoxicity against african green monkey Vero 76 cells assessed as reduction in cell viability after 48 to 96 hrs by MTT method
    Cytotoxicity against african green monkey Vero 76 cells assessed as reduction in cell viability after 48 to 96 hrs by MTT method
    [PMID: 25464882]
    In Vitro

    Clofazimine (0.0625-2 mg/L, 14 d) exerts no apparent activity against M. tuberculosis during the first 2–4 days of exposure, exhibits a concentration-dependent antimicrobial activity after 1 week: bacteriostatic activity at concentrations at or below the 0.25 mg/L MIC and bactericidal activity at concentrations above the MIC. INH is used as positive control.[3].
    Clofazimine (10 μM, 24 h) inhibits the growth of hematological cancer cell lines (Jurkat, U266, Namalwa, K562, HL60)[4].
    Clofazimine (1-50 μM, 12-48 h) shows a dose- and time-dependent inhibitory effect for U266[4].
    Clofazimine (10 μM, 24-48 h) depolarizes the mitochondrial membrane, significantly increases active caspase-3 level (25-fold) and increases the percentage of early and late apoptotic cells in U266[4].

    MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

    In Vivo

    Clofazimine (100,50 mg/kg, p.o., once per day for 14 d) exhibits a delayed antimicrobial activity against Mycobacterium tuberculosis in mice[3].

    MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

    Animal Model: Female BALB/c mice (age 6–8 weeks, mass 18–20 g)[3]
    Dosage: 100, 50, 25, 12.5, 6.25, 3.125 or 1.5625 mg/kg
    Administration: Oral gavage (p.o.), once per day for 14 d
    Result: Exhibited an increase of the lung bacterial load during the first 7 days of treatment, and decreased the CFU counts in the lungs of mice after 10 days of treatment.
    Significantly declined the lung CFU counts in 100 or 50 mg/ kg group at 14th day.
    Clinical Trial
    Molecular Weight

    473.40

    Formula

    C27H22Cl2N4

    CAS No.
    Appearance

    Solid

    Color

    Pink to red

    SMILES

    CC(/N=C1C(NC2=CC=C(Cl)C=C2)=CC3=NC4=C(C=CC=C4)N(C5=CC=C(Cl)C=C5)C3=C/1)C

    Shipping

    Room temperature in continental US; may vary elsewhere.

    Storage

    4°C, protect from light

    *In solvent : -80°C, 1 year; -20°C, 6 months (protect from light)

    Solvent & Solubility
    In Vitro: 

    DMSO : 6.25 mg/mL (13.20 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

    H2O : < 0.1 mg/mL (insoluble)

    Preparing
    Stock Solutions
    Concentration Solvent Mass 1 mg 5 mg 10 mg
    1 mM 2.1124 mL 10.5619 mL 21.1238 mL
    5 mM 0.4225 mL 2.1124 mL 4.2248 mL
    View the Complete Stock Solution Preparation Table

    * Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
    Storage method and period of stock solution: -80°C, 1 year; -20°C, 6 months (protect from light). When stored at -80°C, please use it within 1 year. When stored at -20°C, please use it within 6 months.

    • Molarity Calculator

    • Dilution Calculator

    Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

    Mass
    =
    Concentration
    ×
    Volume
    ×
    Molecular Weight *

    Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

    This equation is commonly abbreviated as: C1V1 = C2V2

    Concentration (start)

    C1

    ×
    Volume (start)

    V1

    =
    Concentration (final)

    C2

    ×
    Volume (final)

    V2

    In Vivo Dissolution Calculator
    Please enter the basic information of animal experiments:

    Dosage

    mg/kg

    Animal weight
    (per animal)

    g

    Dosing volume
    (per animal)

    μL

    Number of animals

    Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
    Calculation results:
    Working solution concentration: mg/mL
    Purity & Documentation

    Purity: 99.79%

    References

    Complete Stock Solution Preparation Table

    * Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
    Storage method and period of stock solution: -80°C, 1 year; -20°C, 6 months (protect from light). When stored at -80°C, please use it within 1 year. When stored at -20°C, please use it within 6 months.

    Optional Solvent Concentration Solvent Mass 1 mg 5 mg 10 mg 25 mg
    DMSO 1 mM 2.1124 mL 10.5619 mL 21.1238 mL 52.8095 mL
    5 mM 0.4225 mL 2.1124 mL 4.2248 mL 10.5619 mL
    10 mM 0.2112 mL 1.0562 mL 2.1124 mL 5.2809 mL
    • No file chosen (Maximum size is: 1024 Kb)
    • If you have published this work, please enter the PubMed ID.
    • Your name will appear on the site.
    Help & FAQs
    • Do most proteins show cross-species activity?

      Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

    Your Recently Viewed Products:

    Inquiry Online

    Your information is safe with us. * Required Fields.

    Product Name

     

    Requested Quantity *

    Applicant Name *

     

    Salutation

    Email Address *

     

    Phone Number *

    Department

     

    Organization Name *

    City

    State

    Country or Region *

         

    Remarks

    Bulk Inquiry

    Inquiry Information

    Product Name:
    Clofazimine
    Cat. No.:
    HY-B1046
    Quantity:
    MCE Japan Authorized Agent: